These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1433432

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intranasal desmopressin-associated hyponatremia: a case report and literature review.
    Bernstein SA, Williford SL.
    J Fam Pract; 1997 Feb; 44(2):203-8. PubMed ID: 9040524
    [Abstract] [Full Text] [Related]

  • 5. Hyponatremic seizures in a child treated with desmopressin to control enuresis. A rational approach to fluid intake.
    Beach PS, Beach RE, Smith LR.
    Clin Pediatr (Phila); 1992 Sep; 31(9):566-9. PubMed ID: 1468178
    [No Abstract] [Full Text] [Related]

  • 6. Severe hyponatremia caused by intranasal desmopressin for nocturnal enuresis.
    Kallio J, Rautava P, Huupponen R, Korvenranta H.
    Acta Paediatr; 1993 Oct; 82(10):881-2. PubMed ID: 8241652
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
    Robson WL, Leung AK, Norgaard JP.
    J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
    [Abstract] [Full Text] [Related]

  • 10. Hyponatraemia and cerebral convulsion due to short term DDAVP therapy for control of enuresis nocturna.
    Schwab M, Wenzel D, Ruder H.
    Eur J Pediatr; 1996 Jan; 155(1):46-8. PubMed ID: 8750810
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dangers of intranasal desmopressin for nocturnal enuresis.
    Bamford MF, Cruickshank G.
    J R Coll Gen Pract; 1989 Aug; 39(325):345-6. PubMed ID: 2556566
    [No Abstract] [Full Text] [Related]

  • 15. Hyponatremic seizure in a child using desmopressin for nocturnal enuresis.
    Schwartz ID.
    Arch Pediatr Adolesc Med; 1998 Oct; 152(10):1037-8. PubMed ID: 9790620
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyponatremia in patients with nocturnal enuresis treated with DDAVP.
    Robson WL, Nørgaard JP, Leung AK.
    Eur J Pediatr; 1996 Nov; 155(11):959-62. PubMed ID: 8911897
    [Abstract] [Full Text] [Related]

  • 19. Hyponatraemia and cerebral convulsion due to DDAVP administration in patients with enuresis nocturna or urine concentration testing.
    Schwab M, Ruder H.
    Eur J Pediatr; 1997 Aug; 156(8):668. PubMed ID: 9266206
    [No Abstract] [Full Text] [Related]

  • 20. Side effects and complications of treatment with desmopressin for enuresis.
    Robson WL, Leung AK.
    J Natl Med Assoc; 1994 Oct; 86(10):775-8. PubMed ID: 7807562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.